Vivanza Bioscience Financials

BSE: 530057

₹1.75

₹0.01 (0.57%)

As on 04-Sep-2026IST

Market cap

₹7 Cr

Revenue (TTM)

₹116 Cr

P/E Ratio

15.4

P/B Ratio

1.6

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Operating Revenue	116.26	115.91	7.42	27.84	17.81	10.40
Total Income	116.73	116.02	7.48	27.89	18.28	11.23
Total Expenditure	115.76	115.17	7.78	26.76	17.14	10.45
EBITDA	0.51	0.74	-0.36	1.07	0.67	-0.05
Depreciation	0.02	0.02	0.01	0.01	0.00	0.01
EBIT	0.48	0.72	-0.37	1.06	0.67	-0.06
Interest	0.31	0.28	0.36	0.42	0.43	0.43
Other Income	0.47	0.11	0.06	0.05	0.48	0.83
Exceptional Items	--	--	--	--	--	--
Profit before Tax	0.64	0.54	-0.67	0.70	0.72	0.33
Provision for Tax	0.19	0.15	0.01	0.15	0.12	0.00
Profit after Tax	0.46	0.39	-0.67	0.55	0.60	0.33
Minority Interest	--	--	--	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	0.45	0.39	-0.67	0.55	0.60	0.33

Liabilities (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Shareholder's Funds	4.36	4.36	3.96	4.64	4.09	3.49
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.88	0.88	3.33	2.68	1.43	2.60
Current Liabilities	16.85	16.85	9.15	12.18	16.95	9.47
Total Liabilities	22.09	22.09	16.45	19.50	22.48	15.56

Assets (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Non-Current Assets	2.44	3.03	4.07	3.76	2.92	3.11
Current Assets	19.06	19.05	12.38	15.74	19.55	12.45
Total Assets	22.09	22.09	16.45	19.50	22.48	15.56
Total Debt*	--	10.19	8.65	5.17	8.00	5.51
Net Current Assets	2.20	2.20	3.23	3.56	2.60	2.98
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Cash From Operating Activities	--	-2.58	-2.50	2.04	-0.95	2.47
Cash Flow from Investing Activities	--	-0.12	-0.01	-0.04	--	--
Cash from Financing Activities	--	2.65	2.46	-1.98	1.03	-2.48
Net Cash Inflow / Outflow	--	-0.05	-0.05	0.03	0.09	-0.01

Financials Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Adjusted EPS (₹)	0.11	0.10	-0.17	0.14	0.15	0.08
Cash EPS (₹)	0.11	0.10	-0.17	0.14	0.15	0.09
Adjusted Book Value (₹)	1.13	1.09	0.99	1.16	1.02	0.87
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-0.64	-0.62	0.51	-0.24	6.17
Free Cash Flow per Share (₹)	--	-0.75	-0.71	0.40	-0.34	5.15

Profitability Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
ROCE (%)	--	6.09	-2.74	10.18	10.83	12.25
ROE (%)	10.19	9.48	-15.67	12.54	15.78	10.01
ROA (%)	2.37	2.05	-3.75	2.61	3.15	2.77
EBIT Margin (%)	0.42	0.62	-4.97	3.81	3.74	-0.60
Net Margin (%)	0.39	0.34	-9.01	1.96	3.27	2.97
Cash Profit Margin (%)	0.00	0.36	-8.89	2.01	3.37	3.27

Growth Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Revenue Growth (%)	734.98	1,461.44	-73.33	56.31	71.22	5.18
EBIT Growth (%)	182.85	293.80	-134.83	59.02	1,175.00	-166.94
Net Profit Growth (%)	153.64	158.51	-223.17	-8.52	79.67	342.02
EPS Growth (%)	153.21	158.52	-223.17	-8.56	79.59	342.29
Book Value Growth (%)	--	9.95	-14.53	13.38	17.13	10.54

Valuation Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Price / Earnings	15.42	17.85	--	49.63	125.69	22.66
Price / Book Value	1.55	1.62	2.01	5.86	18.38	21.61
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	17.60	20.23	-56.16	28.56	72.57	104.51
Close Price (₹)	1.82	1.76	1.99	6.79	18.80	18.87
High Price (₹)	2.72	2.94	9.54	17.86	20.78	21.00
Low Price (₹)	1.52	1.75	1.99	5.70	11.56	6.34
Market Cap (₹ Cr)	7.00	7.04	7.96	27.16	75.20	75.46

Solvency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debt to Equity	0.20	2.34	2.18	1.11	1.95	1.58
Short term debt to equity ratio	--	2.14	1.34	0.54	1.60	0.83
Current Ratio	1.13	1.13	1.35	1.29	1.15	1.31
Quick Ratio	0.92	0.92	1.11	1.13	1.01	1.06
Interest Coverage	3.08	2.92	-0.86	2.66	2.68	1.77

Operating Efficiency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debtors to sales (%)	10.65	10.68	108.57	41.46	70.08	75.39
Asset Turnover	6.03	6.02	0.41	1.33	0.94	0.87
Receivable days	--	32.19	481.83	157.48	208.25	247.26
Inventory Days	--	9.15	104.96	29.38	50.25	54.08
Payable days	--	15.65	290.39	125.07	166.22	176.75
Cash Conversion Cycle	--	25.69	296.40	61.79	92.27	124.59

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.